重组人干扰素α2b阴道泡腾胶囊治疗宫颈人乳头瘤病毒感染的临床研究

Clinical Study of Recombinant Human Interferon α2b Vaginal Effervescent Capsule in the Treatment of Human Papillomavirus Infection

目的研究重组人干扰素α2b阴道泡腾胶囊治疗宫颈人乳头瘤病毒感染的临床疗效。方法选取我院2016年3月~2017年3月收治的96例HPV感染患者,采用随机数字表法将其分为实验组与参照组,各48例。实验组患者采用重组人干扰素α2b阴道泡腾胶囊治疗,参照组患者采用复方沙棘籽油栓治疗,对比两组患者的HPV转阴率、治疗有效率及HC2值,并观察不良反应。结果实验组患者的HPV转阴率为87.23%,高于参照组的33.33%,差异具有统计学意义(P<0.05)。实验组患者的宫颈糜烂面治疗总有效率为91.67%,高于参照组的75.00%,差异具有统计学意义(P<0.05)。疗程结束1个月时,两组的HC2值比较,差异无统计学意义(P>0.05);实验组患者在3个月、6个月后的HC2值低于参照组,差异具有统计学意义(P<0.05)。两组患者的不良反应比较,差异无统计学意义(P>0.05)。结论应用重组人干扰素α2b阴道泡腾胶囊治疗HPV感染,对促使HPV转阴、缩小宫颈糜烂面均有积极作用,且不良反应少、安全性高。

Objective To study the clinical efficacy of recombinant human interferon α2 b vaginal effervescent capsule in the treatment of human papillomavirus infection.Methods 96 patients with HPV infection who were admitted to our hospital from March 2016 to March 2017 were randomly divided into experimental group and reference group,48 cases each.Patients in the experimental group were treated with recombinant human interferon α2 b vaginal effervescent capsule,and patients in the reference group were treated with compound seabuckthorn seed oil suppository.The HPV conversion rate,treatment efficiency and HC2 value were compared between the two groups,and adverse reactions were observed.Results The HPV conversion rate of the experimental group was87.23%,which was higher than that of the reference group 33.33%,and the difference was statistically significant（ P 〈0.05）.The total effective rate of cervical erosion in the experimental group was 91.67%,which was higher than that in the reference group 75.00%,and the difference was statistically significant（P〈0.05）.1 months after the end of the course,the HC2 value of the two groups was not statistically significant（P 〉0.05）.The HC2 value of the patients in the experimental group was lower than the reference group in 3 months and 6 months after the treatment,and the difference was statistically significant（ P〈0.05）.There was no significant difference in adverse reactions between the two groups（P 〉0.05）.Conclusion The use of recombinant human interferon α2 b vaginal effervescent capsule in the treatment of HPV infection has a positive effect on promoting HPV to negative and narrowing the cervical erosion surface,and has fewer adverse reactions and high safety.